Insider Trading & Executive Data
Start Free Trial
11 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Alpha Pro Tech Ltd. manufactures disposable protective apparel (shoe covers, gowns, face masks including a NIOSH-approved N95) and building-weatherization products (REX housewrap, synthetic underlayment), selling primarily into U.S. cleanroom, medical, industrial and residential construction markets. The business combines U.S. plants (Valdosta, GA; Nogales, AZ), a 41.66% joint venture manufacturing presence in India, and third‑party contract manufacturers in Asia and Mexico, with total consolidated sales of $57.8M in 2024. Management stresses product innovation, proprietary materials and single‑use attributes that reduce cross‑infection and installation labor; key near‑term drivers are housing starts (Building Supply) and episodic demand for protective apparel (public‑health surge events). Recent performance shows modest revenue pressure in 2024, margin resilience but compressed operating income due to higher SG&A, and continued use of share repurchases as a capital‑allocation tool.
Compensation at a small, manufacturing‑heavy firm like Alpha Pro Tech is likely to balance modest cash pay with meaningful equity incentives; the filings show stock‑based compensation rose materially (from $170k to $463k in 2024), suggesting increased reliance on equity to align management with long‑term shareholder outcomes. Performance metrics that will plausibly drive short‑ and long‑term pay include consolidated sales (especially Building Supply recovery), gross margins/EBITDA, operating cash flow and working‑capital efficiency (inventory and DSO), plus product‑development and regulatory compliance milestones for medical products. Given exposure to tariffs, freight and input costs, LTIP metrics may incorporate margin or total shareholder return to motivate cost control and strategic sourcing/insourcing decisions. For regulatory‑sensitive product lines (FDA/NIOSH), companies in this industry also commonly tie bonuses to quality/compliance KPIs and on‑time delivery metrics to avoid recall or inspection setbacks.
Insider trades in Alpha Pro Tech can be particularly informative because the company is small‑cap with concentrated operations and a relatively small float; insider purchases or sales may move investor sentiment materially. Watch for trading activity around discrete catalysts — quarterly releases, tariff announcements (notably the Feb 2025 tariffs called out by management), major distributor wins/losses, inventory builds, and JV developments in India — all of which can materially affect near‑term revenue and margin outlook. Given the company’s use of repurchases (≈$4.45M in 2024; ~$2.0M YTD 2025) and increased stock‑based pay, insiders may rely on 10b5‑1 plans or trade during repurchase periods; absence of purchases together with active repurchases or insider selling can be a red flag for cash‑flow/liquidity concerns. Finally, insiders are subject to U.S. reporting (Form 3/4/5) and typical blackout windows around earnings and material regulatory events (FDA/NIOSH), so time clustering of Form 4s around these events is worth monitoring.